Actionable. Accessible. Affordable. SARS-CoV-2 (COVID-19) Testing,
Just in Time (JIT).

Mesa. Positively impacting human health.
Collaborate with Us
Mesa Biotech is a healthcare test and data company that provides actionable information through trusted, PCR-based infectious disease testing—anytime, anywhere.*

Accurate data where it matters, so you can act now.

Wide access to polymerase chain reaction (PCR) based, JIT testing enables instant mobility, appropriate treatments, and surveillance.

Trusted PCR performance, JIT – Just in Time.

Actionable, JIT infectious disease and information solutions that allow decentralized testing at central laboratory standards.
time-img

Time to result
~30 minutes

easy-to-use-img

Easy
to use

small-footprint-img

Small
footprint

How our technology works

OSCAR—OSCillating Amplification Reaction, Mesa’s patented PCR technology, enables rapid exponential amplification while reducing overall thermocycling times.
Benefits
The Accula System is a sample-to-answer nucleic acid PCR amplification platform for just in time testing, with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays.
The Accula Workflow
prepare-sample-img

01Collect

Simple nasal swab specimen collection.
load-samples-img

02Load & Run

Dispense the buffer into the cassette, close the dock lid
and walk away.

read-samples-img

03Read

When notified by the dock, remove the cassette and read the test results.

Our products

We offer PCR-based tests on the Accula™ System for Flu A/B and RSV in addition to our SARS-CoV-2 test. The Accula System has received EUA for SARS-CoV-2, the virus responsible for COVID-19.

Accula Dock
Accula SARS-CoV-2
Accula Flu A/Flu B
Accula RSV

The Accula System has received Emergency Use Authorization for SARS-CoV-2 (the virus responsible for COVID-19). The Accula Flu A/Flu B and the Accula RSV tests have obtained CE mark in the EU, and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the US Food and Drug Administration (FDA).

Get in touch with us to learn more.

Let’s discuss how we can work together for solutions that are quickly deployed and highly dependable.
*Requires patient care setting